Skip to content

The effect of progressive muscle relaxation training on anxiety, depression and quality of life in cancer patients under chemotherapy

The effect of progressive muscle relaxation training on anxiety, depression and quality of life in cancer patients under chemotherapy in Tabriz Hematology & Oncology Center-1388

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138804172103N3
Enrollment
60
Registered
2010-02-19
Start date
2009-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Training. Condition 2: Training. Training in activities of daily living Care involving use of rehabilitation procedure

Interventions

Patients in 3-6 case groups will be trained to progressive muscle relaxation technique. We advise doing these techniques as self-help in the hospital and after discharge home at least 2 or 3 times a d
the muscles are tensed (10 seconds) and relaxed (20 seconds) in sequence as per the following progressive pattern: the tension of the lower arms, upper arms, lower legs, upper legs, stomach, chest ,sh

Sponsors

Hematology and oncology research center, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Agreed to participate, Ability to read and write Farsi, Age range of 15-65 years, Receiving minimum 2 cycles of chemotherapy, Having mental health Inclusion Criteria: receiving pharmacological and non pharmacological interventions for Anxiety and Depression, history of chronic and high risk disease as diabetes, receiving both chemotherapy and radiotherapy, Patients with subscale scores 0-7 (HADS-A), 0-4 (HADS-D), or 0-10 (HADS-T)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Level of anxiety and depresion. Timepoint: 1 and 3 Month after intervention. Method of measurement: HADS questionnairre.;Dimentions of quality of life. Timepoint: 1 and 3 Month after intervention. Method of measurement: EORTC QLQ-C30 questionnairre.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Iraj Asvadi Kermani

Tabriz University of Medical Sciences

asvadikermani@tbzmed.ac.ir+98 41 1334 3844

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026